FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/104190 [Registered on: 18/02/2026] Trial Registered Prospectively
Last Modified On: 17/02/2026
Post Graduate Thesis  Yes 
Type of Trial  BA/BE 
Type of Study   Randomized control trial 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   The study checks whether adding morphine to a local anesthetic injection before laparoscopic gallbladder removal surgery patients to see which gives better pain control during and after surgery 
Scientific Title of Study   A comparative study of the effect of addition of morphine to ropivacaine and ropivacaine alone for preemptive transverse abdominis plane block on the perioperative analgesia on patients undergoing laparoscopic cholecystectomy -a randomized control trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Aravindu 
Designation  Post graduate 
Affiliation  Bangalore Medical College and Research Institute 
Address  Door no 30 Jaraka bande forest quaters Kammagondanahalli Jalahalli west Bangalore 560015

Bangalore
KARNATAKA
560015
India 
Phone  9535481142  
Fax    
Email  dr.aravindu7@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Divya shukla 
Designation  Assistant professor 
Affiliation  Bangalore Medical College and Research Institute 
Address  BMCRI superspeciality hospital fort K R road Bangalore 560002

Bangalore
KARNATAKA
560002
India 
Phone  9945659167  
Fax    
Email  divyashukla17sep@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Aravindu 
Designation  Post graduate 
Affiliation  Bangalore Medical College and Research Institute 
Address  Door no 30 Jaraka bande forest quaters Kammagondanahalli Jalahalli west Bangalore 560015

Bangalore
KARNATAKA
560015
India 
Phone  9535481142  
Fax    
Email  dr.aravindu7@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Dr Aravindu 
Address  Door no 30 Jaraka Bande Forest quaters Kammagondanahalli Jalahalli west Bangalore 560015 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Aravindu  Bangalore medical college and attached hospitals  Department of Anaesthesiology,MPB 3rd floor K R road Fort Bangalore 560002
Bangalore
KARNATAKA 
9535481142

dr.aravindu7@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee Bangalore medical college and research institute  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K819||Cholecystitis, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Ropivacaine   20cc of 0.2% of ropivacaine with 3cc of normal saline given in transverse abdominis plane block The study conducted for the duration of 1 year 7 months 
Intervention  Ropivacaine with morphine  20cc of 0.2% ropivacaine with morphine 0.05mg/kg body weight given in transverse abdominis plane block The study conducted for the duration of 1 year 7 months 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients who are willing to give informed consent
ASA grade 1
Patients with BMI 18.5-25
Patients undergoing laparoscopic cholecystectomy surgeries lasting less than 4 hours 
 
ExclusionCriteria 
Details  Patients refusal
Patients with history of coagulopathy
Patients with history of allergic to local anaesthetic
Patients with severe systemic disease
Psychiatric illness
Chronic medication taking for pain
Patients requiring postoperative mechanical ventilation
Localized infection over injection point
Technical failure 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Double Blind Double Dummy 
Primary Outcome  
Outcome  TimePoints 
Visual analogue score  24 hours 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the time to first rescue analgesia & number of doses of rescue analgesia  24 hours 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   02/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Researchers who provide a methodologically sound proposal.

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response (Others) - 

  6. For how long will this data be available start date provided 02-03-2026 and end date provided 02-03-2031?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   A comparative study of the effect of addition of morphine to ropivacaine and ropivacaine alone for preemptive transverse abdominis plane block on the peri operative analgesia on patients undergoing laparoscopic cholecystectomy is a double blinded randomized control trial
The primary outcome to assess analgesic efficacy with respect to VAS score and the secondary outcome to assess the intraoperative total opioid consumption and to assess intraoperative hemodynamic changes and to assess time for the first rescue analgesia and total number of doses of rescue analgesia in 24 hours 
Study will be conducted in Bangalore medical college attached hospitals with sample size of 40
Duration of study is from July 2025 to December 2026
 
Close